A Phase 2, Randomized, Double-Masked, Controlled, Proof-of-Concept Study to Evaluate the Safety and Biological Activity of a Water-free Tacrolimus Ophthalmic Solution (NOV05) for the Treatment of Non-Infectious Anterior Uveitis
Latest Information Update: 23 Dec 2025
At a glance
- Drugs Tacrolimus (Primary)
- Indications Uveitis
- Focus Adverse reactions; First in man; Proof of concept
- Acronyms EYETAC
- Sponsors Novaliq
Most Recent Events
- 23 Dec 2025 New trial record